Seawater Nasal Wash to Relieve COVID-19 Nasal Symptoms and Reduce SARS-CoV-2 Viral Load.

NACompletedINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

July 29, 2021

Primary Completion Date

March 18, 2022

Study Completion Date

March 18, 2022

Conditions
SARS-CoV2 Infection (COVID-19)URTI - Viral Upper Respiratory Tract Infection
Interventions
DEVICE

Device: Physiomer undiluted seawater nasal spray

"In this study, subjects are asked to adhere to the following dosage during the 3 weeks of the study:~* Nasal wash four times every day~* These washes are to be carried out in each nostril~* By continuously pressing the spray for 3 seconds in each nostril~* Subjects are recommended to distribute the 4 nasal washes as follows:~ * 1st : morning~ * 2nd : midday~ * 3rd : afternoon~ * 4th : evening Subjects will be instructed to maintain daily nasal wash over the 3 weeks study period even in case of earlier nasal symptoms resolution, in order to assess the impact of nasal wash on viral load and other symptoms."

Trial Locations (1)

95000

Le Carreau, Cergy

Sponsors
All Listed Sponsors
collaborator

EVAMED

OTHER

lead

Laboratoire de la Mer

INDUSTRY

NCT04916639 - Seawater Nasal Wash to Relieve COVID-19 Nasal Symptoms and Reduce SARS-CoV-2 Viral Load. | Biotech Hunter | Biotech Hunter